Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS101 for Atopic Dermatitis
NCT00927212Phase 2Terminated
- Sponsor
- BioMAS Ltd
- Start
- Jun 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AS-101 in atopic dermatitis (AD), sponsored by BioMAS Ltd. Started Jun 2009; status: terminated.
02
Drugs
AS-101
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00927212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927212.